Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers (Cell Death & Disease, (2021), 12, 3, (258), 10.1038/s41419-021-03540-y)

François Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, Allan Sauvat, Mathilde Roumier, Delphine Cantin, Emeline Colomba, Julien Rohmer, Fanny Pommeret, Giulia Baciarello, Christophe Willekens, Marc Vasse, Frank Griscelli, Jean Eudes Fahrner, Anne Gaëlle Goubet, Agathe Dubuisson, Lisa Derosa, Nitharsshini Nirmalathasan, Delphine Bredel, Séverine MouraudCaroline Pradon, Annabelle Stoclin, Flore Rozenberg, Jérôme Duchemin, Georges Jourdi, Syrine Ellouze, Françoise Levavasseur, Laurence Albigès, Jean Charles Soria, Fabrice Barlesi, Eric Solary, Fabrice André, Frédéric Pène, Félix Ackerman, Luc Mouthon, Laurence Zitvogel, Aurélien Marabelle, Jean Marie Michot, Michaela Fontenay, Guido Kroemer

    Research output: Contribution to journalComment/debate

    Abstract

    Correction to: Cell Death and Disease (2021) https://doi.org/10.1038/s41419-021-03540-y, published online 11 March 2021 In this article the Funding section has been added: “European Union Horizon 2020 research project Oncobiome (grant number 825410)” The original article has been corrected.

    Original languageEnglish
    Article number142
    JournalCell Death and Disease
    Volume15
    Issue number2
    DOIs
    Publication statusPublished - 1 Feb 2024

    Cite this